生物瓣膜血栓致早期人工瓣膜功能障碍:超声心动图的作用
该回顾性病例对照研究纳入1997年1月至2016年12月共94例生物瓣膜血栓(BPVT)和188例结构性衰竭(SF)患者,发现BPVT组早期人工瓣膜功能障碍(PVD)比例显著高于SF组(88% vs 11%,p<0.001),且从植入到PVD时间更短(26个月 vs 74个月,p<0.001);多数BPVT患者初始诊断时无症状,但症状恶化迅速,需更早干预。
要点
- BPVT组88%为早期PVD,SF组仅11%,提示早期PVD更可能由血栓所致。
- BPVT从植入到PVD中位时间26个月,短于SF的74个月。
- 初始诊断PVD时81%的BPVT患者无症状,多由常规监测TTE发现。
核心结论
- 多数BPVT所致PVD患者初始诊断时无症状,诊断基于常规监测TTE(常在5年内进行);BPVT为急性病程,需及时诊断,因患者病情迅速恶化;需进一步研究以确定是否应对生物瓣膜患者考虑常规监测TTE以识别BPVT症状前特征。
研究设计与样本
- 回顾性病例对照研究,纳入1997年1月至2016年12月所有疑似(影像诊断)或确诊(组织病理诊断)的BPVT病例,按年龄、性别、瓣膜位置1:2匹配因结构性衰竭(SF)行瓣膜取出的患者;BPVT 94例(疑似51例,确诊43例),SF 188例;患者年龄61±9岁,男性61例(65%);瓣膜位置:主动脉瓣56%,二尖瓣26%,三尖瓣15%,肺动脉瓣3%。
诊断标准与关键数值
- PVD定义为瓣膜植入时基线跨瓣压差增加50%以上,并按植入后时间分为早期(≤5年)或晚期(>5年)。
临床应用与阅片要点
- 原文建议需进一步研究以确定是否应对生物瓣膜患者考虑常规监测TTE以识别BPVT症状前特征,从而提供有效、适当的治疗。
局限性
- 原文结论指出需进一步研究以确定是否应对生物瓣膜患者考虑常规监测TTE以识别BPVT症状前特征。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The purpose of this study was to review the institutional practice of surveillance transthoracic echocardiography (TTE) for diagnosing early prosthetic valve dysfunction (PVD).
BACKGROUND: Bioprosthetic valve thrombosis (BPVT) is an important cause of PVD, and guidelines do not recommend routine TTE during the first 5 years after valve implantation.
METHODS: The authors performed a retrospective case-control study of all suspected (imaging diagnosis) or confirmed (histopathological diagnosis) cases of BPVT from January 1997 through December 2016. Patients were matched 1:2 (age, sex, prosthesis position) to patients whose prostheses were explanted because of structural failure (SF). PVD was defined as a 50% increase above baseline gradient at valve implantation and classified as early (≤5 years) or late (>5 years) after implantation.
RESULTS: There were 94 BPVT (51 suspected, 43 confirmed) and 188 SF cases; patient age 61 ± 9 years; men 61 (65%). The prosthesis positions were aortic 56%; mitral 26%; tricuspid 15%; and pulmonary 3%. Early PVD was more common in the BPVT versus SF group: 83 of 94 (88%) versus 20 of 188 (11%) (p < 0.001). Time from implantation to PVD was shorter for BPVT than SF: 26 months (interquartile range [IQR]: 12 to 43 months) versus 74 months (IQR: 48 to 102 months) (p < 0.001). At the initial PVD diagnosis, 81% of BPVT and 90% of SF patients were asymptomatic. However, BPVT patients had rapid symptomatic deterioration, requiring intervention sooner after PVD diagnosis: 6 months (IQR: 4 to 7 months) versus 51 months (IQR: 22 to 55 months) (p < 0.001).
CONCLUSIONS: Most patients with PVD due to BPVT were asymptomatic at initial diagnosis, which was made based on routine surveillance TTE, often performed before 5 years. BPVT, an acute disease process, requires timely diagnosis because patient conditions rapidly deteriorate. Further studies are needed to determine whether routine surveillance TTE should be considered for patients with bioprosthetic valves to identify pre-symptomatic features of BPVT in order to provide effective, appropriate therapy.
引用
- Egbe A, Pislaru SV, Ali MA, et al. Early Prosthetic Valve Dysfunction Due to Bioprosthetic Valve Thrombosis: The Role of Echocardiography. JACC Cardiovasc Imaging. 2017. PMID: 29055629. doi:10.1016/j.jcmg.2017.06.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。